Crovalimab Gets First Nod In China For PNH, Fiercer Global Competition Awaits

 
• By Lisa Takagi
  
Crovalimab received global first approval in China and awaits approval decisions in the US, Europe and Japan.
Crovalimab receives global-first approval in China, awaits approval decisions in US, Europe and Japan • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia